<div id="readability-page-1"><div><p>The Stockholm stock exchange opened Monday with a slight uptick. Viscaria's share price surged following a buy recommendation from Handelsbanken.</p><p>   After 24 minutes of trading, the OMXS30 index was up 0.16 percent at 2,845.86. During the day, the index has fluctuated between a low of -0.05 percent and a high of 0.23 percent. </p><p>The broader OMXSPI was up 0.15 percent.</p><table><tbody><tr><td>Stock</td><td>Price Change</td><td>Comment</td></tr><tr><td></td><td></td><td></td></tr><tr><td>Viscaria</td><td>12.2%</td><td>Handelsbanken initiates coverage with a buy rating and a target price of 27 kronor</td></tr><tr><td>Addvise</td><td>6.0%</td><td>Major shareholder Amplex raises the offer to shareholders in the medical technology group Addvise Group to 1.72 kronor in cash per share and 0.52 kronor per warrant</td></tr><tr><td>Vitrolife</td><td>4.5%</td><td>Dagens industri issues a buy recommendation</td></tr><tr><td>Skanska</td><td>1.1%</td><td>Announces several major deals this morning. Secures an order in the USA worth 1.1 billion kronor. Sells properties in Copenhagen for 1.5 billion kronor. Invests 244 million Norwegian kroner in a residential project in Trondheim</td></tr><tr><td>EQT</td><td>0.8%</td><td>Acquires the operator of Arlanda Express</td></tr><tr><td>Minesto</td><td>0.4%</td><td>Rejects damages claim from a former major shareholder regarding participation in a rights issue</td></tr><tr><td>Arise</td><td>0.0%</td><td>Purchases a 10-megawatt wind farm for around 1.2 million euros</td></tr><tr><td>Intrum</td><td>0.0%</td><td>Records a write-down of 3.4 billion kronor in the fourth quarter, mainly relating to goodwill</td></tr><tr><td>Coor</td><td>-0.5%</td><td>Appoints Patrik Sjölund as new CFO</td></tr><tr><td>Astra Zeneca</td><td>-1.0%</td><td>Announces that the LATIFY lung cancer study missed its primary endpoint. Meanwhile, Enhertu receives breakthrough status in the USA</td></tr><tr><td>Alvotech</td><td>-2.8%</td><td>Begins sales in Europe of a biosimilar to Simponi</td></tr></tbody></table></div></div>

ALVO

<p>Viscaria 的股票在 Handelsbanken 发布买入推荐并设定目标价为 27 克朗后上涨了 12.2%。Addvise 在 Amplex 提高报价后上涨了 6%。Vitrolife 在 Dagens industri 的买入推荐下上涨了 4.5%。Skanska 在宣布重大交易后上涨了 1.1%。EQT、Minesto 和 Arise 的股价变化不大，而 Intrum 则记录了显著的减值。Coor 任命了一位新首席财务官，阿斯利康面临研究挫折，Alvotech 开始在欧洲销售一种生物仿制药</p>

斯德哥尔摩快讯 - Viscaria 因获得买入推荐而股价飙升